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Background
I would like to compliment Noakes et al. on their well-
controlled study comparing effects of different diets on
body composition and cardiovascular risk [1]. The
authors suggested that a very-low-carbohydrate diet
(VLCARB) may not be associated with protein-sparing,
because their dual-energy X-ray absorptiometry (DEXA)
data indicated that both VLCARB and very-low-fat diet
resulted in significantly more loss of lean mass than the
high-unsaturated fat diet. It should be noted, however,
that DEXA provides a measure of lean soft tissue (LST),
and the original notion that LST hydration is constant is
not correct. Rather, LST hydration varies as a function of
extra- and intracellular water distribution [16]. I feel it is
very unlikely that the VLCARB group catabolized more
muscle protein than the high-unsatured fat diet group.
This commentary provides some basic information on
metabolic adaptations that lead to sparing of muscle pro-
tein during a VLCARB, and reviews studies examining the
effects of VLCARB interventions on body composition.
Metabolic adaptations in VLCARB
It is frequently claimed that a VLCARB sets the stage for a
significant loss of muscle mass as the body recruits amino
acids from muscle protein to maintain blood glucose via
gluconeogenesis. It is true that animals share the meta-
bolic deficiency of the total (or almost total) inability to
convert fatty acids to glucose [18]. Thus, the primary
source for a substrate for gluconeogenesis is amino acid,
with some help from glycerol from fat tissue triglycerides.
However, when the rate of mobilization of fatty acids
from fat tissue is accelerated, as, for example, during a
VLCARB, the liver produces ketone bodies. The liver can-
not utilize ketone bodies and thus, they flow from the
liver to extra-hepatic tissues (e.g., brain, muscle) for use as
a fuel. Simply stated, ketone body metabolism by the
brain displaces glucose utilization and thus spares muscle
mass. In other words, the brain derives energy from stor-
age fat during a VLCARB.
Glycolytic cells and tissues (e.g., erythrocytes, renal
medulla) will still need some glucose, because they do not
have aerobic oxidative capacity and thus cannot use
ketone bodies. However, glycolysis in these tissues leads
to the release of lactate that is returned to the liver and
then reconverted into glucose (the Cori cycle). Energy for
this process comes from the increased oxidation of fatty
acids in the liver. Thus, glycolytic tissues indirectly also
run on energy derived from the fat stores.
The hormonal changes associated with a VLCARB include
a reduction in the circulating levels of insulin along with
increased levels of glucagon. Insulin has many actions, the
most well-known of which is stimulation of glucose and
amino acid uptake from the blood to various tissues. This
is coupled with stimulation of anabolic processes such as
protein, glycogen and fat synthesis. Glucagon has oppos-
ing effects, causing the release of glucose from glycogen
and stimulation of gluconeogenesis and fat mobilization.
Thus, the net stimulus would seem to be for increasing
muscle protein breakdown. However, a number of studies
indicate that a VLCARB results in body composition
changes that favour loss of fat mass and preservation in
muscle mass.
A review of studies
To my knowledge, Benoit et al. published the first system-
atic study of the effect of a VLCARB on composition of
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weight loss [2]. They reported that when a 1,000-kcal
VLCARB (10 g of carbohydrates/day) was fed for 10 days,
seven male subjects lost an average of 600 g/day, of which
97% was fat. As pointed out by Grande [11], however, the
energy value of tissue loss reported by Benoit et al. calcu-
lates out to be about 7,000 kcal/day, a highly improbable
level of energy expenditure. In a study by Yang and Van
Itallie [20], effects of starvation, an 800-kcal mixed diet
and an 800-kcal VLCARB on the composition of weight
lost were determined in each of six obese subjects during
three 10-day periods. The results indicated that composi-
tion of weight lost during the VLCARB and the mixed diet
was water 61.2, fat 35.0, protein 3.8, and water 37.1, fat
59.5, protein 3.4 percent, respectively. Thus, the authors
concluded that, over a 10-day period, the energy value of
body constituents lost during adherence to an 800-kcal is
minimally affected by diet composition. Because of meta-
bolic adaptations to prolonged changes in diet composition, the
results of such short-term studies cannot be applied to longer-
term situations. Young et al. compared three diets contain-
ing the same amounts of calories (1,800 kcal/day) and
protein (115 g/day) but differing in carbohydrate content
[3]. After nine weeks on the 30-g, 60-g and 104-g carbohy-
drate diets, weight loss was 16.2, 12.8 and 11.9 kg and fat
accounted for 95, 84, and 75% of the weight loss, respec-
tively. Importantly, underwater weighing was used to
determine body composition. Although these results
should be interpreted cautiously given the low number of
subjects, this study strongly suggests that a VLCARB pro-
motes fat loss while preserving muscle mass, supporting
the notion that "a calorie is not a calorie" [23-25]. Phin-
ney et al. reported that subjects lost 0.7 kg in the first week
of the eucaloric VLCARB, after which their weight
remained stable [15]. Thus, they observed a reduction in
glycogen stores, but excellent preservation of muscle pro-
tein.
More recently, Willi et al. examined the efficacy and met-
abolic impact of a VLCARB in the treatment of morbidly
obese adolescents [4]. Six adolescents weighing an average
of 147.8 kg consumed the VLCARB (25 g of carbohydrate/
day) for 8 weeks. The results indicated that the weight loss
with VLCARB is rapid, consistent, and almost exclusively
from body fat stores. Changes in lean body mass, as esti-
mated from DEXA and urinary creatinine, were not signif-
icant over the term of treatment. Bioelectrical impedance
measurements reflected a greater loss of lean body mass,
but changes in total body fluid and electrolyte content, as
a result of dietary ketosis, may complicate these measure-
ments.
Volek et al. investigated the effects of a six-week VLCARB
on body composition in healthy normal-weight men [5].
Twelve subjects switched from their habitual diet (48%
carbohydrates) to a VLCARB (8% percent carbohydrates)
for six weeks and eight men served as controls, consuming
their normal diet. Although subjects were encouraged to
consume adequate dietary energy to maintain body mass
during the intervention, the results revealed that fat mass
was significantly decreased (-3.4 kg) and lean body mass
significantly increased (+1.1 kg) at week six (as measured
by DEXA). There were no significant changes in composi-
tion in the control group. The authors concluded that a
VLCARB resulted in a significant reduction in fat mass and
an accompanying increase in lean body mass in normal-
weight men. In other words, the entire loss in bodyweight
was from body fat. A subsequent study by Volek et al.
using a VLCARB during energy-restriction noted a greater
decrease in lean body mass in men who consumed a
VLCARB than in men won consumed a high-carbohy-
drate/low-fat diet. However, resting energy expenditure
was maintained in men consuming the VLCARB but
decreased on the high-carbohydrate/low-fat diet, strongly
suggesting that the VLCARB group did not lose muscle
mass.
Vazquez and Adibi reported that proteolysis, as measured
by leucine turnover rate and urinary excretion of 3-meth-
ylhistidine, was not significantly different between isoca-
loric VLCARB and non-ketogenic diet [17]. However, this
study is not relevant to "normal" weight loss diets,
because their subjects consumed only 600 kcal and 8 g of
nitrogen per day. Such a semi-starvation diet will lead to
increased muscle protein catabolism no matter what the
subjects eat.
The perception that the VLCARB leads to progressive loss
of muscle protein apparently comes from the poorly con-
trolled "Turkey Study" published in the New England Jour-
nal of Medicine in 1980 [12]. The authors of this study
reported that the protein-only diet subjects were losing
nitrogen yet gaining potassium. As pointed out by Phin-
ney [13,14], however, potassium and nitrogen losses are
closely related, as they are both contained in lean tissue.
This anomaly occurred because the authors assumed the
potassium intake of their subjects was based upon hand-
book values for raw turkey, but half of this potassium was
being discarded in the unconsumed broth. Deprived of
potassium, these subjects were unable to benefit from die-
tary protein and thus lost muscle mass [14].
How is the preservation of muscle mass brought 
about during a VLCARB?
There are at least four possible mechanisms:
Adrenergic stimulation
The increase in adrenaline may be involved. Low blood
sugar is a potent stimulus to adrenaline secretion and it is
now clear that skeletal muscle protein mass is also regu-
lated by adrenergic influences. For example, Kadowaki etNutrition & Metabolism 2006, 3:9 http://www.nutritionandmetabolism.com/content/3/1/9
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al. demonstrated that adrenaline directly inhibits proteol-
ysis of skeletal muscle [6].
Ketone bodies
As noted above, the liver produces ketone bodies during a
VLCARB and they flow from the liver to extra-hepatic tis-
sues (e.g., brain, muscle) for use as a fuel. In addition,
ketone bodies exert a restraining influence on muscle pro-
tein breakdown. If the muscle is plentifully supplied with
other substrates for oxidation (such as fatty acids and
ketone bodies, in this case), then the oxidation of muscle
protein-derived amino acids is suppressed. Nair et al.
reported that beta-hydroxybutyrate (beta-OHB, a major
ketone body) decreases leucine oxidation and promotes
protein synthesis in humans [7]. Although blood concen-
trations of beta-OHB in their subjects during the infusion
of beta-OHB were much lower than concentrations
observed in humans during fasting, leucine incorporation
into skeletal muscle showed a significant increase (5 to
17%).
Growth hormone (GH)
GH has a major role in regulating growth and develop-
ment. GH is a protein anabolic hormone and it stimulates
muscle protein synthesis. As low blood sugar increases
GH secretions, one could speculate that a VLCARB
increases GH levels. However, Harber et al. reported that
GH secretion was unchanged with 7-day VLCARB/high-
protein diet [8]. Interestingly, they also observed that skel-
etal muscle expression of IGF-I mRNA increased about 2-
fold. A plausible explanation for the increased expression
of IGF-I in muscle is the increased availability of dietary
protein.
Dietary protein
A VLCARB is almost always relatively high in protein.
There is evidence that high protein intake increases pro-
tein synthesis by increasing systemic amino acid availabil-
ity [21], which is a potent stimulus of muscle protein
synthesis [22]. During weight loss, higher protein intake
reduces loss of muscle mass and increases loss of body fat
[9]. It has been proposed that the branched-chain amino
acid leucine interacts with the insulin signaling pathway
to stimulate downstream control of protein synthesis,
resulting in maintenance of muscle mass during periods
of restricted energy intake [10]. A recent study by Harber
et al. reported that a VLCARB/high-protein diet increases
skeletal muscle protein synthesis despite a dramatic
reduction in insulin levels [8].
Conclusion
Although more long-term studies are needed before a firm
conclusion can be drawn, it appears, from most literature
studied, that a VLCARB is, if anything, protective against
muscle protein catabolism during energy restriction, pro-
vided that it contains adequate amounts of protein.
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